BRAINS BIOCEUTICAL APPOINTS FORMER EXECUTIVE DIRECTOR OF GLAXOSMITHKLINE BILL PURVES AS CCO
This announcement comes following the company's previous appointment of former Bio Gen Managing Director as President of Brains Bio
VANCOUVER, BC and UNITED KINGDOM, April 19, 2024 /CNW/ - Bill Purves, an accomplished pharmaceutical executive with unquestionable business acumen and creative foresight, has joined Brains Bioceutical as Chief Commercial Officer (CCO). Purves' impressive history of positioning organizations for success, building strong networks and spurring multi-million dollar sales growth will help take Brains Bioceutical straight to the top.
As CCO of Brains Bioceutical, a global manufacturer of naturally-sourced active pharmaceutical ingredients (APIs), Purves is at the forefront of a new frontier in the research and development of cannabinoids for health and wellness sectors. Responsible for the company's global sales and marketing operations, Purves is poised to diversify the company's unique product offerings while playing a pivotal role in the evolution of cannabinoid science.
After many years in the pharmaceutical industry, combined with time spent working in the cannabis industry, I have the utmost confidence in what we're doing at Brains Bioceutical, says Bill Purves, Chief Commercial Officer of Brains Bioceutical. I'm excited to see the potential of cannabinoid pharmaceuticals come to life and the positive impacts this will have in pharmacological advancements. We are looking at the future of disease treatment and prevention here at Brains Bioceutical.
Continue read on benzinga.com